The role of alternative splicing in cancer: From oncogenesis to drug resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of alternative splicing in cancer: From oncogenesis to drug resistance

Published:2020-12 Issue: Volume:53 Page:100728
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Sciarrillo Rocco,Wojtuszkiewicz Anna,Assaraf Yehuda G.,Jansen Gerrit,Kaspers Gertjan J.L.,Giovannetti Elisa,Cloos Jacqueline

Funder

Cancer Center Amsterdam (CCA) Foundation

Foundation KiKa Children Cancer Free

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference254 articles.

1. A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets;Adamia;Clin. Cancer Res.,2014

2. Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway;Adesso;Oncogene,2013

3. Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators;Aird;Nat. Commun.,2019

4. Position-dependent activity of CELF2 in the regulation of splicing and implications for signal-responsive regulation in T cells;Ajith;RNA Biol.,2016

5. Alternative splicing of Bcl-2-related genes: functional consequences and potential therapeutic applications;Akgul;Cell. Mol. Life Sci.,2004

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SRSF3 suppresses RCC tumorigenesis and progression via regulating SP4 alternative splicing;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-12

2. Role of long noncoding RNAs in the regulation of alternative splicing in glioblastoma;Drug Discovery Today;2024-10

3. The roles and mechanisms of coding and noncoding RNA variations in cancer;Experimental & Molecular Medicine;2024-09-02

4. Overcoming cancer drug-resistance calls for novel strategies targeting abnormal alternative splicing;Pharmacology & Therapeutics;2024-09

5. Writers, readers, and erasers RNA modifications and drug resistance in cancer;Molecular Cancer;2024-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3